A Phase 4 interventional study of Rapid diagnostic and Probiotic in Acute Gastroenteritis, sponsored by Jeffrey Pernica. Completed at 3 sites in Botswana. Open to participants aged 2 Months to 60 Months. Per ClinicalTrials.gov, last updated 2017-03-27.
Sponsored by Jeffrey Pernica · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies testing probiotic in Diarrhea — none open to participants now, none under way, none of them phase 3. Probiotic · Diarrhea.
Among the 20 studies testing probiotic in Diarrhea, this one is the 13th largest by enrollment, is the only one that started in 2014, is the only one in phase 4, and was the 12th registered.
880 studies on the registry are indexed under Diarrhea; 78 are open to participants now.
Browse Diarrhea studies →None of the 20 studies testing probiotic in Diarrhea is open now. The open studies under Diarrhea, anywhere →
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 46 Diarrhea studies recruiting now, 21 (46%) set no upper age limit and 23 (50%) stop at 75 or younger; 19 take children under 18; 15 take healthy volunteers.
This study: 2 Months to 60 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 7 · Phase 3 4 · Phase 4 1
First in 2006; this study’s year is marked. 1 started in 2014.
This study's enrollment of 76 is below the median of 137 across 740 interventional studies indexed under Diarrhea.
Median enrollment 102 across the 20 interventional studies. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 20 have an industry lead sponsor. The 10 most frequent:
Jeffrey Pernica is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Jeffrey Pernica has 1 study filed under Diarrhea — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 20 studies testing probiotic in Diarrhea, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Many children admitted to hospital in Botswana without bloody diarrhoea are presumed to have viral gastroenteritis and so not treated with antibiotics - but they may indeed have a treatable cause for their illness. We will conduct a randomized trial to see if rapid testing using novel methods to identify potentially treatable causes of diarrhoea leads to improved outcomes. We will also be randomizing children to probiotic therapy versus placebo (the standard of care) to see if this treatment decreases the duration of diarrhoea. The proposed study is a pilot trial, necessary before embarking on a large multi-centre trial.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Rapid diagnostic · Dietary Supplement: Probiotic
Other: Rapid diagnostic · Other: Placebo
Dietary Supplement: Probiotic
Other: Placebo
Specimens from rectal mucosa will be obtained using flocked swabs at enrolment. Those in 'rapid diagnostic' groups will have them tested using multiplex PCR the day of enrolment and participants with treatable pathogens will have antimicrobials provided. Those in 'delayed diagnostic' groups will have the swabs batched at tested at the conclusion of the study, being treated as per standard of care.
Lactobacillus reuteri suspended in vegetable oil, 5 drops/day (1 x 10e8 CFU) x 2 months
Identical in appearance to L. reuteri probiotic (same bottle), but simply vegetable oil. Dose is 5 drops/day x 2 months.
Height z-score (HAZ) adjusted for initial HAZ
Time frame: 60 days post-enrollment
mortality
Time frame: 60 days post-enrollment
environmental enteropathy score
Time frame: 60 days post-enrollment
duration of diarrhoea
Note that presence of diarrhoea will be checked daily during admission. Total duration of diarrhoea will be verified with the caregiver by telephone 7 days after the participant was discharged home.
Time frame: estimated average duration ~ 4 days.
Weight z-score (WAZ) adjusted for initial WAZ
Time frame: 60 days after enrolment
The record gives a start of Mar 2014, a primary completion of Nov 2014 and a completion of Dec 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Probiotic